Related references
Note: Only part of the references are listed.Pharmacokinetics and Safety of Chiglitazar, a Peroxisome Proliferator-Activated Receptor Pan-Agonist, in Patients < 65 and ≥ 65 Years With Type 2 Diabetes
Xiaojiao Li et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2021)
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases
Shizuya Yamashita et al.
CURRENT ATHEROSCLEROSIS REPORTS (2020)
Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective
Tara Man Kadayat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
PPARα Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates
Shotaro Kamata et al.
ISCIENCE (2020)
PDK4-Deficiency Reprograms Intrahepatic Glucose and Lipid Metabolism to Facilitate Liver Regeneration in Mice
Yulan Zhao et al.
HEPATOLOGY COMMUNICATIONS (2020)
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome
Letizia Giampietro et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
New dual peroxisome proliferator activated receptor agonistSaroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence
Upendra Kaul et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis
Ming Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate
Benaissa Boubia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
Fan Hong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity
Luca Piemontese et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
The effect of regulating molecules on the structure of the PPAR-RXR complex
Ortal Amber-Vitos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode
Davide Capelli et al.
SCIENTIFIC REPORTS (2016)
Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives
Antonio Simone Lagana et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
ZINC 15-Ligand Discovery for Everyone
Teague Sterling et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γ
Jademilson Celestino dos Santos et al.
JOURNAL OF STRUCTURAL BIOLOGY (2015)
FAF-Drugs3: a web server for compound property calculation and chemical library design
David Lagorce et al.
NUCLEIC ACIDS RESEARCH (2015)
PHYSIOLOGICAL FUNCTIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR β
Jaap G. Neels et al.
PHYSIOLOGICAL REVIEWS (2014)
PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells
Alexandra Rogue et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease
Carla Guzman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Examining the safety of PPAR agonists - current trends and future prospects
Michele Bortolini et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Glycopolypeptides with a Redox-Triggered Helix-to-Coil Transition
Jessica R. Kramer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure
Geert A. A. Nibourg et al.
PLOS ONE (2012)
PPARs and Lipid Ligands in Inflammation and Metabolism
Gregory S. Harmon et al.
CHEMICAL REVIEWS (2011)
The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes
Y. Zhang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
A Comparison of Whole Genome Gene Expression Profiles of HepaRG Cells and HepG2 Cells to Primary Human Hepatocytes and Human Liver Tissues
Steven N. Hart et al.
DRUG METABOLISM AND DISPOSITION (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
Matthew J. Potthoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma
Andrzej Zieleniak et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
Partial agonists activate PPARγ using a helix 12 independent mechanism
John B. Bruning et al.
STRUCTURE (2007)
Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor
Virginie Cerec et al.
HEPATOLOGY (2007)
Safety considerations with fibrate therapy
Michael H. Davidson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
PPARα and PPARγ dual agonists for the treatment of type 2 diabetes and the metabolic syndrome
Catherine Fievet et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Synthesis, biological evaluation, and molecular modeling investigation of new chiral fibrates with PPARα and PPARγ agonist activity
A Pinelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
An overview on biological mechanisms of PPARs
BP Kota et al.
PHARMACOLOGICAL RESEARCH (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Rosiglitazone produces insulin sensitisation by increasing expression of the insulin receptor and its tyrosine kinase activity in brown adipocytes
R Hernandez et al.
DIABETOLOGIA (2003)
Infection of a human hepatoma cell line by hepatitis B virus
P Gripon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
